logoibsc

Medical Researcher Invited Speakers

Professor Simon L. Croft

  simon2                                                                                    

Simon L. Croft, BSC, PGCE, PHD, FRSB, is Professor of Parasitology and Head of the Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine. Mr. Croft has extensive experience and knowledge in antimicrobial and antiprotozoal therapies and supports the adoption of in vitro experimental models for drug discovery and development for infectious diseases. He served as a Senior Scientific Advisor at Invitrocue Limited since May 20, ... 2016 until June 14, 2017. He serves as a Member of Scientific Advisory Board at reViral Ltd. His expertise and knowledge on antimicrobial chemotherapy was developed while working for 5 years with the Wellcome Research Laboratories, Beckenham, UK in the 1980s. Following his return to academia, he focused his research on the identification and evaluation of novel drugs and formulations for the treatment of leishmaniasis, malaria, human African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease). This research included projects on miltefosine, AmBisome and topical paromomycin, all of which reached clinical trials for the treatment of leishmaniasis and many others with academic and industry partners. His work on anti-malarials has included several MMV supported discovery and pre-clinical projects. Current research interests include drug - immune response interactions and PK PD relationships. From 2004 to 2007, he was the First Research & Development Director of the Drugs for Neglected Diseases Initiative (DNDi), Geneva. Mr. Croft trained at the Liverpool School of Tropical Medicine and after Post-Doctoral periods in the laboratory researching drug mechanisms and in disease endemic countries working on the transmission of African trypanosomiasis, he moved to research on drug discovery and development.

       

Professor Ian Goodfellow

botak                                                 

Professor Ian Goodfellow is Professor of Virology and currently the acting deputy head of the Department of Pathology at the University of Cambridge. He studied microbiology and virology as an undergraduate at the University of Warwick, before undertaking a PhD at the University of Nottingham in bacterial genetics. His research career in virology started in 1996 as a postdoctoral research fellow at the University of Reading studying picornavirus-host interactions. This continued at the University of Glasgow until 2003 when he established his own research group at the University of Reading, with the help of a Wellcome Trust career development fellowship, focusing on the study of a family of caliciviruses. Since then he has worked at Imperial College London before moving to the University of Cambridge in October 2012. Research in Professor Goodfellow’s lab is primarily supported by a Wellcome Senior fellowship but he also currently holds grants from the BBSRC and Innovate UK.

His research to date has largely focused on the mechanisms of RNA virus replication and pathogenesis as well as the identification of control measures for the prevention or treatment of infections. He founded the use of reverse genetics to study the molecular basis of norovirus pathogenesis, developing the first infectious reverse genetics system for any norovirus. He has also characterized the role of viral RNA structures in the norovirus life cycle and identified host cell factors that contribute to both virus replication in cell culture but also pathogenesis in the natural host. He has recently expanded his interests to understand the virus-host interface in veterinary pathogens including viral zoonosis. During the 2014-16 Ebola virus epidemic, Professor Goodfellow was involved in the establishment and running of one of the first diagnostic facilities in Sierra Leone in the Bombali district of Sierra Leone. Working with Public Health England, Professor Goodfellow led a team of scientists who establish Ebola virus diagnostic at the Mateneh Ebola Treatment Centre in Makeni. In April 2015, Professor Goodfellow obtained funding from the Wellcome Trust to establish real-time sequencing capacity in a tent next to the diagnostic lab in the treatment centre. Professor Goodfellow and his team established a robust sequencing workflow and were able to sequence clinical samples within 24 hours of isolation from the patient. Working closely with the WHO, Public Health England, the Sierra Leonean Ministry of Health, the US CDC, Professor Goodfellow was heavily involved in the provision of sequencing for use in real-time epidemiological tracing/monitoring of Ebola infections in Sierra Leone and (in collaboration with Loman) neighbouring Guinea. Following the end of the epidemic, Professor Goodfellow has established the University of Makeni Infectious Disease Research Laboratory, which now provides in country next generation sequencing and laboratory support to researchers working within Sierra Leone.

 
 

Dr. Nethia Mohana Kumaran


nethiasmall                                                 


Dr. Nethia Mohana Kumaran graduated with BSc (Hons) Microbiology from Universiti Sains Malaysia and is the recipient of the Professor E. Balasingam Gold Medal Award (Best Graduating  Student in Biological Sciences, USM, 2005). After completing her MSc (Oncology) at the University of Nottingham, UK, she received a scholarship from the Ministry of Higher Education Malaysia to pursue her doctorate in Medicine at the University of Sydney (USyd), Australia. While in Sydney, she received the prestigious New South Wales Scholar Award to continue her PhD work at USyd.

She also received two awards for Best Oral Presentation by a Young Investigator from the Australasian Society of Dermatology Research and the awards were recognized as significant achievement by the USyd Medical School in 2012. Nethia joined Universiti Sains Malaysia in 2013 as a lecturer. Her main research focus is to identify pro-survival proteins which contribute to Nasopharyngeal cancer (NPC) cell survival using the CRISPR/Cas9 technology and later target these proteins with BH3 mimetic drugs. She is a life-member of the NPC Society of Malaysia, an active member and ambassodar of the European Association for Cancer Research (EACR) and a member of the Young Scientists Network- Academy of Sciences Malaysia. Nethia continues to win numerous accolades for her work including the coveted L'Oreal-UNESCO for Women in Science National Fellowship and the MAKNA Cancer Research award in 2016.

 

Dr. Reuben Sharma

   sharma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

Reuben Sharma graduated with a Doctor of Veterinary Medicine (DVM) degree from Universiti Putra Malaysia (UPM) and subsequently pursued a Master in Veterinary Science (MVSc) in wildlife medicine at the same university. He was later awarded a PhD in Molecular Parasitology from the University of Cambridge, United Kingdom. Reuben is a Member of the Royal Society of Biology (MRSB) and a Chartered Biologist (CBiol). He has been appointed as advisor to the World Health Organization (WHO) on zoonotic primate malaria, is a Director on the Executive Board of the World Association for the Advancement of Veterinary Parasitology (WAAVP), and an Affiliate Researcher at the University of Glasgow, UK. He has also been appointed as consultant/expert resource person to various NGO’s and governmental organizations including the World Wide Fund for Nature (WWF), the Department of Wildlife and National Parks Malaysia (DWNP), Department of Veterinary Services Malaysia (DVS), the Ministry of Human Resources Malaysia (MOHR), the Ministry of Natural Resources and Environment Malaysia (NRE), and the Ministry of Health Malaysia (MOH). Reuben has served as President of the Malaysian Society of Parasitology and Tropical Medicine (MSPTM), and is an Executive Council member of the Veterinary Association Malaysian (VAM), a member of the National Wildlife Genetics Advisory Board, and the Orangutan Conservancy USA Veterinary Advisory Group (OVAG). He has also received a number of international awards including the BP Conservation Program Award (twice), the Wildlife Disease Association USA Professional Development Award and the MSPTM medal. He is also the Country Coordinator for the Sakura Science Program Japan. His expertise and research interests include genetics and molecular epidemiology of haemoparasites, zoonotic wildlife diseases, wildlife medicine and conservation.

       

Clinical Invited Speakers

Professor Dale Fisher

  ikan2.001                                                   
 

Prof Dale Fisher

MBBS 1986, FRACP 1993, DTM&H 1993

Head, Clinical Director and Senior Consultant, Division of Infectious Diseases

Chair, Infection Control, National University Hospital

Experience:

  • Royal Darwin Hospital, Australia 1992 to 2004
  • National University Hospital, Singapore 2004 till to date

Clinical Interests:   

  • General tropical Infectious Disease
  • Outpatient Parenteral Antibiotic Therapy (OPAT)
  • MRSA control in healthcare settings
  • Outbreak investigations and management (Global and Local)

Awards:  

  • Courage Medal, Courage foundation Singapore March - May'03
  • RACP John Sands Medal for outstanding contribution to College Affairs (May 2006)
  • NUS Yong Loo Lin School of Medicine Faculty Teaching excellence award - 2008 & 2009

Sample Publications:

  1. Cryptococcal meningitis (C. neoformans var gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea.  D Lalloo, D Fisher, S Naraqi et al.  Quarterly Journal of Medicine, 1994;87: 343-349.
  2. Endemic Melioidosis in Tropical Northern Australia: A 10-Year Prospective Study and Review of the Literature.  Bart J Currie, Dale A Fisher, Diane M Howard et al. Clin Infect Dis 2000;31:981-986
  3. Hospital Care for Aboriginal and Torres Strait Islanders: Appropriateness and decision-making.  Dale Fisher, Tarun Weeramanthri; Editorial Med J Aust 2002; 176: 49-50The Bali Bombings of October 12, 2002:
  4. The Bali Bombings of October 12, 2002: Lessons in Disaster Management for Physicians. Dale Fisher, James Burrow. Int Med J 2003; 33: 125-126
  5. Atypical presentations of SARS. Dale A Fisher, Tow-Keang Lim, Yean-Teng Lim, Kamaljit S Singh, Paul A Tambyah. The Lancet 17 May 2003. Vol. 361; P1740.
  6. Preventing local transmission of SARS: lessons from Singapore. Dale A Fisher, Madeleine H L Chew, Yean-Teng Lim and Paul A Tambyah. Published online ahead of print, MJA 19 May 2003. http://www.mja.com.au/public/rop/fis10245_fm.html
  7. Risk Factors for Nephrotoxicity associated with Continuous Vancomycin Infusion in Outpatient Parenteral Antibiotic Therapy. Ingram, Paul; Lye, David; Tambyah, Paul; Goh, Wei; Tam, Vincent; Fisher, Dale. Journal of Antimicrobial Chemotherapy (2008) 62, 168-171.Dengue management; Practical and safe hospital-based outpatient care. Paul R. Ingram, Malcolm Mahadevan, Dale A. Fisher. Trans R Soc Trop Med Hyg (2009) 103, 203-205.
  8. A Cost Analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): An Asian Perspective. Candice Yong, Dale A. Fisher, Grant E. Sklar, Shu-Chuen Li. International Journal of Antimicrobial Agents; 33:1; Jan 2009, pp46-51
  9. Methicillin Resistant Staphylococcus aureus Control in Singapore - Moving Forward. Lynette Pereira, Dale Fisher. Ann Acad Med Singapore 2008;37:891-6.

Teaching Hand Hygiene to Medical Students using a Hands-On Approach. Dale Fisher; Lynette Pereira, Toon Mae Ng; Krista Patlovich, Felicia Teo, Li Yang Hsu; Journal of Hosp Infection; 76:1, Sept 2010, p 86-87

 
   

Professor Dato' Adeeba Kamarulzaman

Adeeba                                                 


Professor Dato' Adeeba Kamarulzaman is a Professor of Medicine & Infectious Diseases and Dean of the Faculty of Medicine, University of Malaya. Professor Kamarulzaman received her medical and specialist training in Melbourne Australia and returned to Malaysia in 1997 to establish the Infectious Diseases Unit at the University Malaya Medical Centre. Under her leadership, the Unit and its research arm the Centre of Excellence for Research in AIDS (CERiA) have expanded to be one of the main tertiary referral and research centres in the country. Professor Kamarulzaman has played a key role in the HIV response in Malaysia and internationally with a particular focus on HIV prevention and treatment amongst marginalized and key affected populations.

She is also presently Chairman of the Malaysian AIDS Foundation and an Executive Council member of the Malaysian AIDS Council, the peak HIV NGO in Malaysia. At the international level, Professor Kamarulzaman is an Executive Council Member of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV. She has received numerous local and international awards and recognition for her contribution to medicine and infectious diseases including an Adjunct Associate Professorship at Yale University, and an Adjunct Professorship at Tulane University, USA. In 2015 she was awarded an Honorary Doctor of Laws from her alma mater Monash University.

 
 

Dato' Dr. Musa Mohd Nordin

  Musaxbg                                                      
   


Dato' Dr. Musa Mohd Nordin

Consultant Paediatrician & Neonatologist, KPJ Damansara Specialist Hospital.

A 1982 graduate of Cardiff University (UK), he obtained his Membership from the Royal College of Physician (UK) in 1985. He is a Fellow of the Royal College of Physicians Edinburgh (1995), Royal College of Paediatrics and Child Health and the Academy of Medicine Malaysia (1997).He served the Ministry of Health for 15 years from 1982 to 1997. Since 1997, he has been a consultant paediatrician and neonatologist at Damansara Specialist Hospital. He is a Clinical Professor of Paediatrics at the KPJ International University College and an international faculty member of Peshawar Medical College, Pakistan.Since 1999, he has served on various international advisory boards related to vaccines & immunisation. He is a founding member of the Asian Strategic Alliance on the Prevention of Pneumococcal Disease (ASAP) and Immunise4Life. Previously, he served on the Asia Pacific Expert
Committee on Immunisation, Asia Pacific COMPAS Advisory Board, Asia Pacific PCV Expert Academy and Asia Pneumococcal Advisory Board. He presently sits on the editorial boards of MIMS Paediatrics, Bangladesh Medical Journal and FIMA Yearbook. He previously served on the editorial board of the Malaysian Journal of Paediatrics & Child Health. He has published numerous articles in peer-reviewed journals and has contributed chapters to 10 book publications. He is the chief-editor of the latest book “Immunisation Controversies- What you really need to know”. He contributed 8 chapters to Elsevier’s New App “Care of Muslim Patients – A Practical Guide”.

He is a board member of the National Neonatology Accreditation Board, Board of Governance, Malaysian National Neonatal Registry and serves on several National Committees in the Ministry of Health (MOH). He completed 2 terms (2005-09) as president of the international Federation of Islamic Medical Associations (FIMA). He is now chairman of the FIMA Advisory Council. He was an advisory board member of the International Society of Tropical Paediatrics (ISTP). He is the past-president of the Perinatal Society of Malaysian (1998) and has been treasurer of the Malaysian Paediatric Association since 1992. He is the founding chairman of two Charity Homes which shelters women and children with HIV/AIDS. He is the chairman of Viva Palestina Malaysia (VPM) and was on the International Viva Palestina 5 Land Convoy from London to Gaza in Oct 2010. He previously served as a member of the Board of Trustees, Malaysian Paediatric Foundation (MPF) and is currently a member of the Board of Trustees, Al-Quds Foundation, Malaysia. He is chairman of the Kuala Lumpur Palestine Film Festival since 2012. He is the recipient of the 2017 FIMA Lifetime Achievement Award. He was the first recipient of the Islamic Medical Association of Malaysia ar-Razi Lifetime Achievement Award in 2015. He was the recipient of the 2012 Outstanding Asian Paediatrician Award from the Asia Pacific Pediatric Association. In 2008, he was conferred the medal “Darjah Paduka Mahkota Perak” (DPMP) by HRH The Sultan of Perak, which carries the title Dato’. During his presidency, FIMA Save Vision, was awarded for excellence in charitable & humanitarian works, the Richard & Hinda Rosenthal Award, by the American College of Physicians, in 2008.

 
         

Professor Datuk Dr. Lokman Hakim Sulaiman

  lokmannbg                                                    
   
Prof. Datuk Dr. Lokman Hakim bin Sulaiman

Datuk Dr. Lokman Hakim S is Professor of Public Health at the International Medical University, Kuala Lumpur. He graduated as Medical Doctor from Universiti Kebangsaan Malaysia, Master in Public Health from National University Singapore and PhD in Medical Parasitology from UKM. He was conferred the Fellow of Academy of Medicine Malaysia and is the current President of the College of Public Health Medicine of the Academy. He is also a Fellow of Academy of Medicine of Singapore. He is an elected Fellow of the Academy of Science Malaysia.

He took optional retirement in July 2017 from the Ministry of Health of Malaysia after serving for more than 32 years, including 18 years as researcher with the Institute for Medical Research, Kuala Lumpur. His last position before retirement was the Deputy Director General of Health (Public Health). His research interest is in infectious disease transmission dynamics and environmental health. He is credited for the establishment of the National Malaria Elimination Program and Lymphatic Filariasis Elimination Program. In Public Health development, he is instrumental in the development of public health physician career pathway, structured public health physician training in MOH and establishment of the sub-specialty program.

He had served in various consultancy capacities to WHO. Among the more recent assignment were, Member of Expert Advisory Group on Environmental Health to the WHO Regional Director of Western Pacific Office (WPRO), 2016, Member of Malaria Advisory Committee WHO Geneva 2015, and Scientific Ad-Hoc Committee for WHO-Tropical Disease Research (TDR) Program, 2016. Recently, he is appointed as a Member of the Pandemic Influenza Preparedness (PIP) Framework Advisory Group to the DG of WHO Geneva, for the period 2017-2019.